Responses
Scientific Abstracts
Oral Presentations
Abstract Session: Update on non anti-TNF biologics
OP0024 Safety and efficacy of SBI-087 in subjects with active rheumatoid arthritis in a phase 2 randomized, double-blind, placebo-controlled study
Compose a Response to This Article
Other responses
No responses have been published for this article.